Corcept Therapeutics Competitors and Similar CompaniesClear all
Corcept Therapeutics's competitors and similar companies include BeyondSpring and Telix Pharmaceuticals.
 Corcept Therapeutics Corcept Therapeutics is a pharmaceutical company which discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders. |  BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care. | |
Founding Date | Founding Date 1998 | Founding Date 2010 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Menlo Park, US HQ | Locations Florham Park, US HQ | |
Employees | Employees 20624% increase | Employees 6712% decrease | Employees 415 |
Valuation ($) | Valuation ($) 3.7 b | Valuation ($) 88.3 m | Valuation ($) 4.5 b |
Financial | |||
Revenue (est.) | Revenue (est.) $482.4m (FY, 2023) | Revenue (est.) $1.4m (FY, 2022) | Revenue (est.) $502.5m (FY, 2023) |
Cost of goods | Cost of goods $6.5m (FY, 2023) | Cost of goods N/A | Cost of goods $181.4m (FY, 2023) |
Gross profit | Gross profit $475.9m (FY, 2023) | Gross profit N/A | Gross profit $321.3m (FY, 2023) |
Net income | Net income $106.1m (FY, 2023) | Net income ($36.3m) (FY, 2022) | Net income $5.2m (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised $ 80.1m | Total funding raised $ 36.1m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
BeyondSpring
HQ
Florham Park, US
Employees
67↓ 12% decrease
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View companyTelix Pharmaceuticals
HQ
North Melbourne, AU
Employees
415
Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.
View company